Search

everythinglearnresearchcommunity

for

Search:↓

Skin changes like hair loss, white patches, and nail changes are common in children after bone marrow transplants, often linked to chronic rejection.

Examining Survivin levels may help understand premature greying of hair.

Ruxolitinib may help treat hair loss and symptoms in patients with chronic graft-versus-host disease.

Wearing fire helmets may worsen lichen planopilaris in firefighters.

Adjusting the medication tacrolimus resolved a boy's red nail beds after a stem cell transplant.

The FDA approved Litfulo® for treating severe alopecia areata in people aged 12 and older.

There have been major advances in diagnosing and treating hair loss over the last 30 years, with new drugs and improved hair transplant techniques.

Skin's Regulatory T cells are crucial for maintaining skin health and could be targeted to treat immune-related skin diseases and cancer.

The document provides a practical guide for diagnosing and treating various types of hair loss.

Alopecia Areata is an autoimmune disease causing hair loss, with no cure yet, but research may lead to new treatments.

Antioxidant nanoparticles show promise for treating inflammatory diseases but need more research for safe and effective use.

Azathioprine's effectiveness and safety require careful monitoring and more research, especially regarding its use with corticosteroids and the role of TPMT status in patients.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Alopecia Areata is an autoimmune disease affecting hair follicles, influenced by genetic and environmental factors, with rodent models being essential for research.

Mesenchymal stem cells show promise for treating various skin conditions and may help regenerate hair.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Alopecia areata causes hair loss, has no cure, and various treatments exist.

Alopecia Areata is an autoimmune condition causing hair loss, influenced by genetics, environment, and possibly improved by anti-MIF therapy, with many patients experiencing regrowth within a year.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Understanding how cells die in the skin is important for treating skin diseases and preventing hair loss.

Systemic Lupus Erythematosus has varied symptoms and is hard to diagnose, affecting many body parts and requiring careful clinical judgment.

Interferons are effective for some skin conditions and cancers, but can have side effects and need more research for optimal use.

Ritlecitinib effectively regrows hair in severe alopecia areata and is well tolerated.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

Biomedical engineers are crucial for developing better treatments for chronic and autoimmune diseases.

Alopecia Areata is an autoimmune condition causing hair loss with no cure and treatments that often don't work well.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

A group has developed therapies that show promise for treating cancer and various other conditions.

Both atopy and eosinophilia are linked to more severe hair loss in people with alopecia areata.

Hair transplants can cause hair loss if done while lichen planopilaris is active; wait until it's inactive for two years and check with a scalp biopsy first.